Home biotech
 

Keywords :   


Tag: biotech

Peter Thiel Explains Biotech Investing Rationale: Get Rid of Randomness

2015-09-12 08:36:44| Biotech - Topix.net

Peter Thiel knows a promising tech startup when he sees one. The investor was the first outside investor in Facebook.

Tags: peter investing explains rid

 

BIO Announces San Diego as industrial biotech conference host.

2015-09-11 14:31:11| Industrial Newsroom - All News for Today

As announced by BIO, 2016 World Congress on Industrial Biotechnology will be held April 17–20 in San Diego, CA. Call for papers for this event invites industry leaders as well as those from academia and financial sectors to submit proposals and individual papers beginning September 17, 2015. Abstracts or proposals for 15 min presentation on any program track are sought for breakout panels, breakout papers, posters, and Green Tech investor sessions.

Tags: san industrial conference host

 
 

Actelion in talks with ZS Pharma amid surge in biotech deal-making

2015-09-11 10:33:22| Biotech - Topix.net

Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers. Actelion, Europe's biggest biotech company, and ZS Pharma both issued statements late on Thursday stating that they had held preliminary discussions, but did not specifically mention if the talks were related to a buyout.

Tags: talks surge biotech pharma

 

Wall Street bounces back with Apple, biotech

2015-09-11 00:00:57| Biotech - Topix.net

US stocks ended higher today in another day of broad swings as investors showed nervousness ahead of next week's much-anticipated Federal Reserve meeting, but gains in Apple and biotech shares supported the day's advance. Apple's shares rose 2.2 percent to $112.57, rebounding from losses the day before when the iPhone and iPad maker unveiled new offerings.

Tags: back street wall apple

 

Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune

2015-09-10 20:44:16| Biotech - Topix.net

Adaptimmune just hit its all-time low on the NASDAQ after closing just above $11 per share. Since offering shares in early May, the company has traded largely in the $14.50-$15.50 price range.

Tags: market cancer leaves bargain

 

Sites : [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] next »